Progress in understanding the biology of the human mutagen LINE-1

Human Mutation

Volumn 28, Issue 6, 2007, Pages 527-539

  Babushok, Daria V ^a   Kazazian Jr , Haig H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antisense transcription; Bicistronic transcript; Gene disruption; Genome evolution; Human mutation; L1; LINE 1; Retrotransposition; RNAi; Termination reinitiation

Indexed keywords

MUTAGENIC AGENT;

BIOLOGY; CELL TYPE; GENOME; HUMAN; LONG INTERSPERSED REPEAT; PRIORITY JOURNAL; RETROPOSON; REVIEW; RNA TRANSLATION; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; ENDODEOXYRIBONUCLEASES; ENDORIBONUCLEASES; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MUTAGENESIS, INSERTIONAL; RNA-DIRECTED DNA POLYMERASE;

MAMMALIA;

EID: 34248358963     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20486     Document Type: Review

References (160)

1. Alisch RS, Garcia-Perez JL, Muotri AR, Gage FH, Moran JV. 2006. Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev 20:210-224.
2. An W, Han JS, Wheelan SJ, Davis ES, Coombes CE, Ye P, Triplett C, Boeke JD. 2006. Active retrotransposition by a synthetic L1 element in mice. Proc Natl Acad Sci USA 103:18662-18667.
3. Asch HL, Eliacin E, Fanning TG, Connolly JL, Bratthauer G, Asch BB. 1996. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues. Oncol Res 8:239-247.
4. Ast G. 2004. How did alternative splicing evolve? Nat Rev Genet 5: 773-782.
5. Athanikar JN, Badge RM, Moran JV. 2004. A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res 32:3846-3855.
6. Babcock M, Pavlicek A, Spiteri E, Kashork CD, Ioshikhes I, Shaffer LG, Jurka J, Morrow BE. 2003. Shuffling of genes within low-copy repeats on 22q11 (LCR22) by Alu-mediated recombination events during evolution. Genome Res 13:2519-2532.
7. Babushok DV, Ostertag EM, Courtney CE, Choi JM, Kazazian HH Jr. 2006. L1 integration in a transgenic mouse model. Genome Res 16: 240-250.
8. Bailey JA, Liu G, Eichler EE. 2003. An Alu transposition model for the origin and expansion of human segmental duplications. Am J Hum Genet 73:823-834.
9. Batzer MA, Deininger PL. 2002. Alu repeats and human genomic diversity. Nat Rev Genet 3:370-379.
10. Becker KG, Swergold G, Ozato K, Thayer RE. 1993. Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element. Hum Mol Genet 2: 1697-1702.
11. Belancio VP, Hedges DJ, Deininger P. 2006. LINE-1 RNA splicing and influences on mammalian gene expression. Nucleic Acids Res 34: 1512-1521.
12. Belancio VP, Whelton M, Deininger P. Requirements for polyadenylation at the 3′ end of LINE-1 elements. Gene (in press).
13. Belgnaoui SM, Gosden RG, Semmes OJ, Haoudi A. 2006. Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int 6:13.
14. Berry C, Hannenhalli S, Leipzig J, Bushman FD. 2006. Selection of target sites for mobile DNA integration in the human genome. PLoS Comput Biol 2:e157.
15. Bibillo A, Eickbush TH. 2002. The reverse transcriptase of the R2 non-LTR retrotransposon: continuous synthesis of cDNA on non-continuous RNA templates. J Mol Biol 316:459-473.
16. Bibillo A, Eickbush TH. 2004. End-to-end template jumping by the reverse transcriptase encoded by the R2 retrotransposon. J Biol Chem 279: 14945-14953.
17. Bogerd HP, Wiegand HL, Hulme AE, Garcia-Perez JL, O'Shea KS, Moran JV, Cullen BR. 2006. Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci USA 103:8780-8785.
18. Boissinot S, Chevret P, Furano AV. 2000. L1 (LINE-1) retrotransposon evolution and amplification in recent human history. Mol Biol Evol 17: 915-928.
19. Branciforte D, Martin SL. 1994. Developmental and cell type specificity of LINE-1 expression in mouse testis: implications for transposition. Mol Cell Biol 14:2584-2592.
20. Bratthauer GL, Fanning TG. 1992. Active LINE-1 retrotransposons in human testicular cancer. Oncogene 7:507-510.
21. Bratthauer GL, Fanning TG. 1993. LINE-1 retrotransposon expression in pediatric germ cell tumors. Cancer 71:2383-2386.
22. Brouha B, Meischl C, Ostertag E, de Boer M, Zhang Y, Neijens H, Roos D, Kazazian HH Jr. 2002. Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet 71:327-336.
23. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH Jr. 2003. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 100:5280-5285.
24. Burke WD, Malik HS, Jones JP, Eickbush TH. 1999. The domain structure and retrotransposition mechanism of R2 elements are conserved throughout arthropods. Mol Biol Evol 16:502-511.
25. Buzdin A, Ustyugova S, Gogvadze E, Vinogradova T, Lebedev Y, Sverdlov E. 2002. A new family of chimeric retrotranscripts formed by a full copy of U6 small nuclear RNA fused to the 3′ terminus of 11. Genomics 80: 402-406.
26. Buzdin A, Gogvadze E, Kovalskaya E, Volchkov P, Ustyugova S, Illarionova A, Fushan A, Vinogradova T, Sverdlov E. 2003. The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination. Nucleic Acids Res 31:4385-4390.
27. Casaregola S, Neuveglise C, Bon E, Gaillardin C. 2002. Ylli, a non-LTR retrotransposon L1 family in the dimorphic yeast Yarrowia lipolytica. Mol Biol Evol 19:664-677.
28. Cavalier-Smith T. 1985. The evolution of genome size. New York: Wiley. 534p.
29. Chen JM, Chuzhanova N, Stenson PD, Ferec C, Cooper DN. 2005a. Meta-analysis of gross insertions causing human genetic disease: novel mutational mechanisms and the role of replication slippage. Hum Mutat 25:207-221.
30. Chen JM, Stenson PD, Cooper DN, Ferec C. 2005b. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet 117:411-427.
31. Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, Landau NR, Weitzman MD. 2006a. APOBEC3A is a potent inhibitor of adenoassociated virus and retrotransposons. Curr Biol 16:480-485.
32. Chen JM, Ferec C, Cooper DN. 2006b. LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease: mutation detection bias and multiple mechanisms of target gene disruption. J Biomed Biotechnol 2006:56182.
33. Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, Esnault C, Heidmann T, Greene WC. 2006. High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci USA 103: 15588-15593.
34. Christensen SM, Eickbush TH. 2005. R2 target-primed reverse transcription: ordered cleavage and polymerization steps by protein subunits asymmetrically bound to the target DNA. Mol Cell Biol 25:6617-6628.
35. Conley ME, Partain JD, Norland SM, Shurtleff SA, Kazazian HH Jr. 2005. Two independent retrotransposon insertions at the same site within the coding region of BTK. Hum Mutat 25:324-325.
36. Cordaux R, Hedges DJ, Herke SW, Batzer MA. 2006. Estimating the retrotransposition rate of human Alu elements. Gene 373:134-137.
37. Cost GJ, Feng Q, Jacquier A, Boeke JD. 2002. Human L1 element target-primed reverse transcription in vitro. EMBO J 21:5899-5910.
38. Dante R, Dante-Paire J, Rigal D, Roizes G. 1992. Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors. Anticancer Res 12:559-563.
39. Deininger PL, Batzer MA. 1999. Alu repeats and human disease. Mol Genet Metab 67:183-193.
40. Dewannieux M, Esnault C, Heidmann T. 2003. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet 35:41-48.
41. Dombroski BA, Mathias SL, Nanthakumar E, Scott AF, Kazazian HH Jr. 1991. Isolation of an active human transposable element. Science 254: 1805-1808.
42. Dombroski BA, Feng Q, Mathias SL, Sassaman DM, Scott AF, Kazazian HH Jr, Boeke JD. 1994. An in vivo assay for the reverse transcriptase of human retrotransposon L1 in Saccharomyces cerevisiae. Mol Cell Biol 14:4485-4492.
43. Duvernell DD, Turner BJ. 1998. Swimmer 1, a new low-copy-number LINE family in teleost genomes with sequence similarity to mammalian L1. Mol Biol Evol 15:1791-1793.
44. Eichler EE. 2001. Recent duplication, domain accretion and the dynamic mutation of the human genome. Trends Genet 17:661-669.
45. Eickbush DG, Luan DD, Eickbush TH. 2000. Integration of Bombyx mori R2 sequences into the 28S ribosomal RNA genes of Drosophila melanogaster. Mol Cell Biol 20:213-223.
46. Eickbush TH, Malik HS. 2002. Origins and evolution of retrotransposons. In: Craig NL, editor. Mobile DNA II. Washington, DC: ASM Press. p 1111-1144.
47. Ergun S, Buschmann C, Heukeshoven J, Dammann K, Schnieders F, Lauke H, Chalajour F, Kilic N, Stratling WH, Schumann GG. 2004. Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues. J Biol Chem 279:27753-27763.
48. Esnault C, Maestre J, Heidmann T. 2000. Human LINE retrotransposons generate processed pseudogenes. Nat Genet 24:363-367.
49. Fanning T, Singer M. 1987. The LINE-1 DNA sequences in four mammalian orders predict proteins that conserve homologies to retrovirus proteins. Nucleic Acids Res 15:2251-2260.
50. Feng Q, Moran JV, Kazazian HH Jr, Boeke JD. 1996. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 87:905-916.
51. Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA. 1999. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80:1312-1321.
52. Gasior SL, Wakeman TP, Xu B, Deininger PL. 2006. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol 357: 1383-1393.
53. Geiduschek EP, Kassavetis GA. 2001. The RNA polymerase III transcription apparatus. J Mol Biol 310:1-26.
54. George JA, Burke WD, Eickbush TH. 1996. Analysis of the 5′ junctions of R2 insertions with the 28S gene: implications for non-LTR retrotransposition. Genetics 142:853-863.
55. Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A, Gill R, Celera Holt RA, Adams MD, Amanatides PG, Baden-Tillson H, Barnstead M, Chin S, Evans CA, Ferriera S, Fosler C, Glodek A, Gu Z, Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG, Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahill P, Kana A, Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra M, Schein J, Bosdet I, Fjell C, Jones S, Krzywinski-M, Mathewson C, Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman S, Geer K, Chen Y, Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Cooney AJ, D'Souza LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler DA, Zhang Z, Bailey JA, Eichler EE, Tuzun E, Birney E, Mongin E, Ureta-Vidal A, Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D, Alexandersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels S, Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar Alba M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O, Poliakov A, Hubner N, Ganten D, Goesele C, Hummel O, Kreitler T, Lee YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H, Jacob HJ, Bromberg S, Gullings-Handley J, Jensen-Seaman MI, Kwitek AE, Lazar J, Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM, Rice S, Goodstadt L, Beatson SA, Ernes RD, Winter EE, Webber C, Brandt P, Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara P, Hardison RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko A, Riemer C, Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K, Andrews TD, Caccamo M, Clamp M, Clarke L, Curwen V, Durbin R, Eyras E, Searle SM, Cooper GM, Batzoglou S, Brudno M, Sidow A, Stone EA, Payseur BA, Bourque G, Lopez-Otin C, Puente XS, Chakrabarti K, Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A, Tesler G, Pevzner PA, Haussler D, Roskin KM, Baertsch R, Clawson H, Furey TS, Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR, Trumbower H, Weirauch M, Cooper DN, Stenson PD, Ma B, Brent M, Arumugam M, Shteynberg D, Copley RR, Taylor MS, Riethman H, Mudunuri U, Peterson J, Guyer M, Felsenfeld A, Old S, Mockrin S, Collins F. 2004. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428: 493-521.
56. Gilbert N, Lutz-Prigge S, Moran JV. 2002. Genomic deletions created upon LINE-1 retrotransposition. Cell 110:315-325.
57. Gilbert N, Lutz S, Morrish TA, Moran JV. 2005. Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol 25:7780-7795.
58. Goodier JL, Ostertag EM, Kazazian HH Jr. 2000. Transduction of 3′-flanking sequences is common in L1 retrotransposition. Hum Mol Genet 9:653-657.
59. Goodier JL, Ostertag EM, Engleka KA, Seleme MC, Kazazian HH Jr. 2004. A potential role for the nucleolus in L1 retrotransposition. Hum Mol Genet 13:1041-1048.
60. Goodwin TJ, Ormandy JE, Poulter RT. 2001. L1-like non-LTR retrotransposons in the yeast Candida albicans. Curr Genet 39:83-91.
61. Han JS, Szak ST, Boeke JD. 2004. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 429:268-274.
62. Hayward BE, Zavanelli M, Furano AV, 1997. Recombination creates novel L1 (LINE-1) elements in Rattus norvegicus. Genetics 146:641-654.
63. Hillier LW, Miller W, Birney E, Warren W, Hardison RC, Ponting CP, Bork P, Burt DW, Groenen MA, Delany ME, Dodgson JB, Chinwalla AT, Cliften PF, Clifton SW, Delehaunty KD, Fronick C, Fulton RS, Graves TA, Kremitzki C, Layman D, Magrini V, McPherson JD, Miner TL, Minx P, Nash WE, Nhan MN, Nelson JO, Oddy LG, Pohl CS, Randall-Maher J, Smith SM, Wallis JW, Yang SP, Romanov MN, Rondelli CM, Paton B, Smith J, Morrice D, Daniels L, Tempest HG, Robertson L, Masabanda JS, Griffin DK, Vignal A, Fillon V, Jacobbson L, Kerje S, Andersson L, Crooijmans RP, Aerts J, van der Poel JJ, Ellegren H, Caldwell RB, Hubbard SJ, Grafham DV, Kierzek AM, McLaren SR, Overton IM, Arakawa H, Beattie KJ, Bezzubov Y, Boardman PE, Bonfield JK, Croning MD, Davies RM, Francis MD, Humphray SJ, Scott CE, Taylor RG, Tickle C, Brown WR, Rogers J, Buerstedde JM, Wilson SA, Stubbs L, Ovcharenko I, Gordon L, Lucas S, Miller MM, Inoko H, Shiina T, Kaufman J, Salomonsen J, Skjoedt K, Wong GK, Wang J, Liu B, Yu J, Yang H, Nefedov M, Koriabine M, Dejong PJ, Goodstadt L, Webber C, Dickens NJ, Letunic I, Suyama M, Torrents D, von Mering C, Zdobnov EM, Makova K, Nekrutenko A, Elnitski L, Eswara P, King DC, Yang S, Tyekucheva S, Radakrishnan A, Harris RS, Chiaromonte F, Taylor J, He J, Rijnkels M, Griffiths-Jones S, Ureta-Vidal A, Hoffman MM, Severin J, Searle SM, Law AS, Speed D, Waddington D, Cheng Z, Tuzun E, Eichler E, Bao Z, Flicek P, Shteynberg DD, Brent MR, Bye JM, Huckle EJ, Chatterji S, Dewey C, Pachter L, Kouranov A, Mourelatos Z, Hatzigeorgiou AG, Paterson AH, Ivarie R, Brandstrom M, Axelsson E, Backstrom N, Berlin S, Webster MT, Pourquie O, Reymond A, Ucla C, Antonarakis SE, Long M, Emerson JJ, Betran E, Dupanloup I, Kaessmann H, Hinrichs AS, Bejerano G, Furey TS, Harte RA, Raney B, Siepel A, Kent WJ, Haussler D, Eyras E, Castelo R, Abril JF, Castellano S, Camara F, Parra G, Guigo R, Bourque G, Tesler G, Pevzner PA, Smit A, Fulton LA, Mardis ER, Wilson RK. 2004. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature 432:695-716.
64. Hohjoh H, Singer MF. 1996. Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. EMBO J 15:630-639.
65. Hohjoh H, Singer MF. 1997. Sequence-specific single-strand RNA binding protein encoded by the human LINE-1 retrotransposon. EMBO J 16:6034-6043.
66. Holmes SE, Singer MF, Swergold GD. 1992. Studies on p40, the leucine zipper motif-containing protein encoded by the first open reading frame of an active human LINE-1 transposable element. J Biol Chem 267:19765-19768.
67. Holmes SE, Dombroski BA, Krebs CM, Boehm CD, Kazazian HH Jr. 1994. A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat Genet 7:143-148.
68. Hulme AE, Kulpa DA, Garcia-Perez JL, Moran JV. 2006. The impact of LINE-1 retrotransposition on the human genome. In: Lupski JR, Stankiewicz PT, editors. Genomic disorders: the genomic basis of disease. Totowa, NJ: Humana Press. p 35-55.
69. Hulme AE, Bogerd HP, Cullen BR, Moran JV. Selective inhibition of Alu retrotransposition by APOBEC3G. Gene (in press).
70. Ilves H, Kahre O, Speek M. 1992. Translation of the rat LINE bicistronic RNAs in vitro involves ribosomal reinitiation instead of frameshifting. Mol Cell Biol 12:4242-4248.
71. Ishida Y, Leder P. 1999. RET: a poly A-trap retrovirus vector for reversible disruption and expression monitoring of genes in living cells. Nucleic Acids Res 27:e35.
72. Jurka J. 1997. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci USA 94:1872-1877.
73. Jurka J. 2004- Evolutionary impact of human Alu repetitive elements. Curr Opin Genet Dev 14:603-608.
74. Kazazian HH Jr, Wong C, Youssoufian H, Scott AF, Phillips DG, Antonarakis SE. 1988. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 332:164-166.
75. Kazazian HH Jr. 1999. An estimated frequency of endogenous insertional mutations in humans. Nat Genet 22:130.
76. Kazazian HH. 2004. Mobile elements: drivers of genome evolution. Science 303:1626-1632.
77. Kojima KK, Matsumoto T, Fujiwara H. 2005. Eukaryotic translational coupling in UAAUG stop-start codons for the bicistronic RNA translation of the non-long terminal repeat retrotransposon SART1. Mol Cell Biol 25:7675-7686.
78. Kolosha VO, Martin SL. 1997. In vitro properties of the first ORF protein from mouse LINE-1 support its role in ribonucleoprotein particle formation during retrotransposition. Proc Natl Acad Sci USA 94: 10155-10160.
79. Kolosha VO, Martin SL. 2003. High-affinity, non-sequence-specific RNA binding by the open reading frame 1 (ORF1) protein from long interspersed nuclear element 1 (LINE-1). J Biol Chem 278:8112-8117.
80. Konkel MK, Wang J, Liang P, Batzer MA. Identification and characterization of novel polymorphic LINE-1 insertions through comparison of two human genome sequence assemblies. Gene (in press).
81. Kozak M. 1989. The scanning model for translation: an update. J Cell Biol 108:229-241.
82. Kubo S, Seleme MdC, Soifer HS, Perez JLG, Moran JV, Kazazian HH Jr, Kasahara N. 2006. L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci USA 103:8036-8041.
83. Kulpa DA, Moran JV. 2005. Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum Mol Genet 14:3237-3248.
84. Kulpa DA, Moran JV. 2006. Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat Struct Mol Biol 13: 655-660.
85. Kurose K, Hata K, Hattori M, Sakaki Y. 1995. RNA polymerase III dependence of the human L1 promoter and possible participation of the RNA polymerase II factor YY1 in the RNA polymerase III transcription system. Nucleic Acids Res 23:3704-3709.
86. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
87. Lavie L, Maldener E, Brouha B, Meese EU, Mayer J. 2004. The human L1 promoter: variable transcription initiation sites and a major impact of upstream flanking sequence on promoter activity. Genome Res 14:2253-2260.
88. Leibold DM, Swergold GD, Singer MF, Thayer RE, Dombroski BA, Fanning TG. 1990. Translation of LINE-1 DNA elements in vitro and in human cells. Proc Natl Acad Sci USA 87:6990-6994.
89. Lev-Maor G, Sorek R, Shomron N, Ast G. 2003. The birth of an alternatively spliced exon: 3′ splice-site selection in Alu exons. Science 300:1288-1291.
90. Li PW, Li J, Timmerman SL, Krushel LA, Martin SL. 2006. The dicistronic RNA from the mouse LINE-1 retrotransposon contains an internal ribosome entry site upstream of each ORF: implications for retrotransposition. Nucleic Acids Res 34:853-864.
91. Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, Clamp M, Chang JL, Kulbokas EJ 3rd, Zody MC, Mauceli E, Xie X, Breen M, Wayne RK, Ostrander EA, Ponting CP, Galibert F, Smith DR, DeJong PJ, Kirkness E, Alvarez P, Biagi T, Brockman W, Butler J, Chin CW, Cook A, Cuff J, Daly MJ, DeCaprio D, Gnerre S, Grabherr M, Kellis M, Kleber M, Bardeleben C, Goodstadt L, Heger A, Hitte C, Kim L, Koepfli KP, Parker HG, Pollinger JP, Searle SM, Sutter NB, Thomas R, Webber C, Baldwin J, Abebe A, Abouelleil A, Aftuck L, Ait-Zahra M, Aldredge T, Allen N, An P, Anderson S, Antoine C, Arachchi H, Aslam A, Ayotte L, Bachantsang P, Barry A, Bayul T, Benamara M, Berlin A, Bessette D, Blitshteyn B, Bloom T, Blye J, Boguslavskiy L, Bonnet C, Boukhgalter B, Brown A, Cahill P, Calixte N, Camarata J, Cheshatsang Y, Chu J, Citroen M, Collymore A, Cooke P, Dawoe T, Daza R, Decktor K, DeGray S, Dhargay N, Dooley K, Dorje P, Dorjee K, Dorris L, Duffey N, Dupes A, Egbiremolen O, Elong R, Falk J, Farina A, Faro S, Ferguson D, Ferreira P, Fisher S, FitzGerald M, Foley K, Foley C, Franke A, Friedrich D, Gage D, Garber M, Gearin G, Giannoukos G, Goode T, Goyette A, Graham J, Grandbois E, Gyaltsen K, Hafez N, Hagopian D, Hagos B, Hall J, Healy C, Hegarty R, Honan T, Horn A, Houde N, Hughes L, Hunnicutt L, Husby M, Jester B, Jones C, Kamat A, Kanga B, Kells C, Khazanovich D, Kieu AC, Kisner P, Kumar M, Lance K, Landers T, Lara M, Lee W, Leger JP, Lennon N, Leuper L, LeVine S, Liu J, Liu X, Lokyitsang Y, Lokyitsang T, Lui A, Macdonald J, Major J, Marabella R, Maru K, Matthews C, McDonough S, Mehta T, Meldrim J, Melnikov A, Meneus L, Mihalev A, Mihova T, Miller K, Mittelman R, Mlenga V, Mulrain L, Munson G, Navidi A, Naylor J, Nguyen T, Nguyen N, Nguyen C, Nicol R, Norbu N, Norbu C, Novod N, Nyima T, Olandt P, O'Neill B, O'Neill K, Osman S, Oyono L, Patti C, Perrin D, Phunkhang P, Pierre F, Priest M, Rachupka A, Raghuraman S, Rameau R, Ray V, Raymond C, Rege F, Rise C, Rogers J, Rogov P, Sahalie J, Settipalli S, Sharpe T, Shea T, Sheehan M, Sherpa N, Shi J, Shih D, Sloan J, Smith C, Sparrow T, Stalker J, Stange-Thomann N, Stavropoulos S, Stone C, Stone S, Sykes S, Tchuinga P, Tenzing P, Tesfaye S, Thoulutsang D, Thoulutsang Y, Topham K, Topping I, Tsamla T, Vassiliev H, Venkataraman V, Vo A, Wangchuk T, Wangdi T, Weiand M, Wilkinson J, Wilson A, Yadav S, Yang S, Yang X, Young G, Yu Q, Zainoun J, Zembek L, Zimmer A, Lander ES. 2005. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438:803-819.
92. Luan DD, Korman MH, Jakubczak JL, Eickbush TH. 1993. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 72: 595-605.
93. Lucchinetti E, Feng J, Silva Rd, Tolstonog GV, Schaub MC, Schumann GG, Zaugg M. 2006. Inhibition of LINE-1 expression in the heart decreases ischemic damage by activation of Akt/PKB signaling. Physiol Genomics 25:314-324.
94. Makalowski W, Mitchell GA, Labuda D. 1994. Alu sequences in the coding regions of mRNA: a source of protein variability. Trends Genet 10: 188-193.
95. Malik HS, Burke WD, Eickbush TH. 1999. The age and evolution of non-LTR retrotransposable elements. Mol Biol Evol 16:793-805.
96. Martin SL. 1991. Ribonucleoprotein particles with LINE-1 RNA in mouse embryonal carcinoma cells. Mol Cell Biol 11:4804-4807.
97. Martin F, Maranon C, Olivares M, Alonso C, Lopez MC. 1995. Characterization of a non-long terminal repeat retrotransposon cDNA (L1Tc) from Trypanosoma cruzi: homology of the first ORF with the ape family of DNA repair enzymes. J Mol Biol 247:49-59.
98. Martin SL, Li J, Weisz JA. 2000. Deletion analysis defines distinct functional domains for protein-protein and nucleic acid interactions in the ORF1 protein of mouse LINE-1. J Mol Biol 304:11-20.
99. Martin SL, Bushman FD. 2001. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol Cell Biol 21:467-475.
100. Martin SL, Cruceanu M, Branciforte D, Wai-Lun Li P, Kwok SC, Hodges RS, Williams MC. 2005a. LINE-1 retrotransposition requires the nucleic acid chaperone activity of the ORF1 protein. J Mol Biol 348: 549-561.
101. Martin SL, Li WL, Furano AV, Boissinot S. 2005b. The structures of mouse and human L1 elements reflect their insertion mechanism. Cytogenet Genome Res 110:223-228.
102. Martin SL. 2006. The ORF1 protein encoded by LINE-1: structure and function during L1 retrotransposition. J Biomed Biotechnol 2006:45621.
103. Mathias SL, Scott AF, Kazazian HH Jr, Boeke JD, Gabriel A. 1991. Reverse transcriptase encoded by a human transposable element. Science 254:1808-1810.
104. Matlik K, Redik K, Speek M. 2006. L1 antisense promoter drives tissue-specific transcription of human genes. J Biomed Biotechnol 2006:71753.
105. McMillan JP, Singer MF. 1993. Translation of the human LINE-1 element, L1Hs. Proc Natl Acad Sci USA 90:11533-11537.
106. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, Vogelstein B, Nakamura Y. 1992. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 52:643-645.
107. Minakami R, Kurose K, Etoh K, Furuhata Y, Hattori M, Sakaki Y. 1992. Identification of an internal cis-element essential for the human L1 transcription and a nuclear factor(s) binding to the element. Nucleic Acids Res 20:3139-3145.
108. Mine M, Chen JM, Brivet M, Desguerre I, Marchant D, de Lonlay P, Bernard A, Ferec C, Abitbol M, Ricquier D, Marsac C. 2006. A large genomic deletion in the PDHX gene caused by the retrotranspositional insertion of a full-length LINE-1 element. Hum Mutat 28:137-142.
109. Mitchell GA, Labuda D, Fontaine G, Saudubray JM, Bonnefont JP, Lyonnet S, Brody LC, Steel G, Obie C, Valle D. 1991. Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation. Proc Natl Acad Sci USA 88:815-819.
110. Moran JV, Holmes SE, Naas TP, DeBerardinis RJ, Boeke JD, Kazazian HH. 1996. High frequency retrotransposition in cultured mammalian cells. Cell 87:917-927.
111. Moran JV, DeBerardinis RJ, Kazazian HH Jr. 1999. Exon shuffling by L1 retrotransposition. Science 283:1530-1534.
112. Morrish TA, Gilbert N, Myers JS, Vincent BJ, Stamato TD, Taccioli GE, Batzer MA, Moran JV. 2002. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat Genet 31:159-165.
113. Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM. 1988. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 333:87-90.
114. Muckenfuss H, Hamdorf M, Held U, Perkovic M, Lower J, Cichutek K, Flory E, Schumann GG, Munk C. 2006. APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem 281:22161-22172.
115. Muotri AR, Chu VT, Marchetto MC, Deng W, Moran JV, Gage FH. 2005. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 435:903-910.
116. Musova Z, Hedvicakova P, Mohrmann M, Tesarova M, Krepelova A, Zeman J, Sedlacek Z. 2006. A novel insertion of a rearranged L1 element in exon 44 of the dystrophin gene: further evidence for possible bias in retroposon integration. Biochem Biophys Res Commun 347: 145-149.
117. Nigumann P, Redik K, Matlik K, Speek M. 2002. Many human genes are transcribed from the antisense promoter of L1 retrotransposon. Genomics 79:628-634.
118. Ohshima K, Hattori M, Yada T, Gojobori T, Sakaki Y, Okada N. 2003. Whole-genome screening indicates a possible burst of formation of processed pseudogenes and Alu repeats by particular L1 subfamilies in ancestral primates. Genome Biol 4:R74.
119. Ostertag EM, Kazazian HH Jr. 2001a. Biology of mammalian L1 retrotransposons. Annu Rev Genet 35:501-538.
120. Ostertag EM, Kazazian HH Jr. 2001b. Twin priming: a proposed mechanism for the creation of inversions in L1 retrotransposition. Genome Res 11:2059-2065.
121. Ostertag EM, DeBerardinis RJ, Goodier JL, Zhang Y, Yang N, Gerton GL, Kazazian HHJ. 2002. A mouse model of human L1 retrotransposition. Nat Genet. 32:655-660.
122. Ostertag EM, Goodier JL, Zhang Y, Kazazian HH Jr. 2003. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am J Hum Genet 73:1444-1451.
123. Ostertag EM, Kazazian HH. J. 2006. Retrotransposition and Human Disorders. In: Encyclopedia of Life Sciences: John Wiley & Sons. Ltd: Chichester http://www.els.net/[doi: 10.1038/npg.els.0005492].
124. Perepelitsa-Belancio V, Deininger P. 2003. RNA truncation by premature polyadenylation attenuates human mobile element activity. Nat Genet 35:363-366.
125. Pickeral OK, Makalowski W, Boguski MS, Boeke JD. 2000. Frequent human genomic DNA transduction driven by LINE-1 retrotransposition. Genome Res 10:411-415.
126. Piskareva O, Denmukhametova S, Schmatchenko V. 2003. Functional reverse transcriptase encoded by the human LINE-1 from baculovirus-infected insect cells. Protein Expr Purif 28:125-130.
127. Piskareva O, Schmatchenko V. 2006. DNA polymerization by the reverse transcriptase of the human L1 retrotransposon on its own template in vitro. FEBS Lett 580:661-668.
128. Prak ET, Dodson AW, Farkash EA, Kazazian HH Jr. 2003. Tracking an embryonic L1 retrotransposition event. Proc Natl Acad Sci USA 100:1832-1837.
129. Reznikoff WS. 2003. Tn5 as a model for understanding DNA transposition. Mol Microbiol 47:1199-1206.
130. Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, Garate L, Barrios M, Castillejo JA, Navarro G, Colomer D, Prosper F, Heiniger A, Torres A. 2005. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24:7213-7223.
131. Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA. 1999. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate 39:166-174.
132. Schulz WA, Steinhoff C, Florl AR. 2006. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 310:211-250.
133. Scott AF, Schmeckpepet BJ, Abdelrazik M, Comey CT, O'Hara B, Rossiter JP, Cooley T, Heath P, Smith KD, Margolet L. 1987. Origin of the human L1 elements: proposed progenitor genes deduced from a consensus DNA sequence. Genomics 1:113-125.
134. Seleme MC, Vetter MR, Cordaux R, Bastone L, Batzer MA, Kazazian HH Jr. 2006. Extensive individual variation in L1 retrotransposition capability contributes to human genetic diversity. Proc Natl Acad Sci USA 103:6611-6616.
135. Shi X, Seluanov A, Gorbunova V. 2007. Cell divisions are required for L1 retrotransposition. Mol Cell Biol 27:1264-1270.
136. Singer MF, Krek V, McMillan JP, Swergold GD, Thayer RE. 1993. LINE-1: a human transposable element. Gene 135:183-188.
137. Skowronski J, Fanning TG, Singer MF. 1988. Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol 8:1385-1397.
138. Smit AF. 1999. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr Opin Genet Dev 9:657-663.
139. Soifer HS, Rossi JJ. 2006. Small interfering RNAs to the rescue: blocking L1 retrotransposition. Nat Struct Mol Biol 13:758-759.
140. Speek M. 2001. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol 21:1973-1985.
141. Stankiewicz P, Shaw CJ, Withers M, Inoue K, Lupski JR. 2004. Serial segmental duplications during primate evolution result in complex human genome architecture. Genome Res 14:2209-2220.
142. Stenglein MD, Harris RS. 2006. APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. J Biol Chem 281:16837-16841.
143. Swergold GD. 1990. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol 10:6718-6729.
144. Symer DE, Connelly C, Szak ST, Caputo EM, Cost GJ, Parmigiani G, Boeke JD. 2002. Human 11 retrotransposition is associated with genetic instability in vivo. Cell 110:327-338.
145. Szak ST, Pickeral OK, Makalowski W, Boguski MS, Landsman D, Boeke JD. 2002. Molecular archeology of L1 insertions in the human genome. Genome Biol 3:research0052.
146. Tchenio T, Casella J-F, Heidmann T. 2000. Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res 28:411-415.
147. Trelogan SA, Martin SL. 1995. Tightly regulated, developmentally specific expression of the first open reading frame from LINE-1 during mouse embryogenesis. Proc Natl Acad Sci USA 92:1520-1524.
148. Turelli P, Vianin S, Trono D. 2004. The innate antiretroviral factor APOBEC3G does not affect human LINE-1 retrotransposition in a cell culture assay. J Biol Chem 279:43371-43373.
149. Wang H, Xing J, Grover D, Hedges DJ, Han K, Walker JA, Batzer MA. 2005. SVA elements: a hominid-specific retroposon family. J Mol Biol 354:994-1007.
150. Watanabe T, Takeda A, Tsukiyama T, Mise K, Okuno T, Sasaki H, Minami N, Imai H. 2006. Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes. Genes Dev 20:1732-1743.
151. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn DM, Eddy SR, Elnitski L, Ernes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Grafham D, Graves TA, Green ED, Gregory S, Guigo R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, Karolchik D, Kasprzyk A, Kawai J, Keibler E, Kells C, Kent WJ, Kirby A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, Landers T, Leger JP, Leonard S, Letunic I, Levine R, Li J, Li M, Lloyd C, Lucas S, Ma B, Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH, McCarthy M, McCombie WR, McLaren S, McLay K, McPherson JD, Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, Mongin E, Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash WE, Nelson JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor MJ, Okazaki Y, Oliver K, Overton-Larty E, Pachter L, Parra G, Pepin KH, Peterson J, Pevzner P, Plumb R, Pohl CS, Poliakov A, Ponce TC, Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM, Rubin EM, Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J, Schwartz MS, Schwartz S, Scott C, Seaman S, Searle S, Sharpe T, Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, Smit A, Smith DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M, Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C, Ureta-Vidal A, Vinson JP, Von Niederhausem AC, Wade CM, Wall M, Weber RJ, Weiss RB, Wendl MC, West AP, Wetterstrand K, Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson RK, Winter E, Worley KC, Wyman D, Yang S, Yang SP, Zdobnov EM, Zody MC, Lander ES. 2002. Initial sequencing and comparative analysis of the mouse genome. Nature 420:520-562.
152. Wei W, Gilbert N, Ooi SL, Lawler JF, Ostertag EM, Kazazian HH, Boeke JD, Moran JV. 2001. Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol 21:1429-1439.
153. Weissenbach J. 1993. Microsatellite polymorphisms and the genetic linkage map of the human genome. Curr Opin Genet Dev 3:414-417.
154. Wheelan SJ, Aizawa Y, Han JS, Boeke JD. 2005. Gene-breaking: a new paradigm for human retrotransposon-mediated gene evolution. Genome Res 15:1073-1078.
155. Yang N, Zhang L, Zhang Y, Kazazian HH Jr. 2003. An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res 31:4929-4940.
156. Yang N, Kazazian HH Jr. 2006. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol 13:763-771.
157. Yu F, Zingler N, Schumann G, Stratling WH. 2001. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res 29:4493-4501.
158. Zhang J. 2003. Evolution by gene duplication: an update. Trends Ecol Evol 18:292-298.
159. Zhang XH, Chasin LA. 2006. Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons. Proc Natl Acad Sci USA 103:13427-13432.
160. Zingler N, Willhoeft U, Brose HP, Schoder V, Jahns T, Hanschmann KM, Morrish TA, Lower J, Schumann GG. 2005. Analysis of 5′ junctions of human LINE-1 and Alu retrotransposons suggests an alternative model for 5′-end attachment requiring microhomology-mediated end-joining. Genome Res 15:780-789.